The inflammasome in liver injury and non-alcoholic fatty liver disease

Digestive Diseases

Volumn 32, Issue 5, 2014, Pages 507-515

  Mehal, Wajahat Zafar ^a,b  

^a YALE UNIVERSITY   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Inflammasome; Liver injury; Non alcoholic fatty liver disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOKINE; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA CONVERTING ENZYME; PATTERN RECOGNITION RECEPTOR; PURINERGIC P2X7 RECEPTOR; INTERLEUKIN 1BETA;

ALCOHOL LIVER DISEASE; ARTICLE; CYTOKINE PRODUCTION; HUMAN; INNATE IMMUNITY; KUPFFER CELL; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; MACROPHAGE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; UPREGULATION; CONFERENCE PAPER; CYTOKINE RELEASE; ENZYME ACTIVATION; INFLAMMATION; PROTEIN DEPLETION; ANIMAL; INJURIES; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

ANIMALS; HUMANS; INFLAMMASOMES; INFLAMMATION; LIVER; LIVER CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; RECEPTORS, PATTERN RECOGNITION;

EID: 84904647950     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000360495     Document Type: Article

References (57)

1. Chen GY, Nunez G: Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010; 10: 826-837.
2. Martin P, Leibovich SJ: Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005; 15: 599-607.
3. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tor M, Billiar T: The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 2007; 220: 60-81.
4. Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191- 195.
5. Ea HK, Liote F: Calcium pyrophosphate dihydrate and basic calcium phosphate crystal-induced arthropathies: update on pathogenesis, clinical features, and therapy. Curr Rheumatol Rep 2004; 6: 221-227.
6. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR: Calcium pyrophosphate dihydrate and basic calcium phosphate crystal-induced arthropathies: update on pathogenesis, clinical features, and therapy. J Immunol 2006; 177: 1272-1281.
7. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC: Adenosine 5 ? -triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 2006; 112: 358-404.
8. Kono H, Chen CJ, Ontiveros F, Rock KL: Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest 2010; 120: 1939-1949.
9. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, Vandenabeele P: Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011; 32: 157- 164.
10. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, Ulland TK, Eisenbarth SC, Florquin S, Flavell RA, Leemans JC, Sutterwala FS: Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 2009; 106: 20388- 20393.
11. Eigenbrod T, Park JH, Harder J, Iwakura Y, Nunez G: Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1? released from dying cells. J Immunol 2008; 181: 8194- 8198.
12. Moussion C, Ortega N, Girard JP: The IL-1- like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 2008; 3:e3331.
13. Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5: 331-342.
14. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464: 1357-1361.
15. Mossman BT, Churg A: Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998; 157: 1666-1680.
16. Ioannou GN, Haigh WG, Thorning D, Savard C: Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J Lipid Res 2013; 54: 1326-1334.
17. Allaire GS, Goodman ZD, Ishak KG, Rabin L: Talc in liver tissue of intravenous drug abusers with chronic hepatitis. A comparative study. Am J Clin Pathol 1989; 92: 583-588.
18. West AP, Koblansky AA, Ghosh S: Recognition and signaling by Toll-like receptors. Annu Rev Cell Dev Biol 2006; 22: 409-437.
19. Kerrigan AM, Brown GD: Syk-coupled Ctype lectin receptors that mediate cellular activation via single tyrosine-based activation motifs. Immunol Rev 2010; 234: 335-352.
20. Martinon F, Burns K, Tschopp J: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of pro-IL-?. Mol Cell 2002; 10: 417- 426.
21. Keller M, Ruegg A, Werner S, Beer HD: Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008; 132: 818-831.
22. Wree A, Eguchi A, McGeough MD, Pena CA, Johnson CD, Canbay A, Hoffman HM, Feldstein AE: NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 2013, Epub ahead of print.
23. Kanneganti TD: Central roles of NLRs and inflammasomes in viral infection. Nat Rev Immunol 2010; 10: 688-698.
24. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G: The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009; 10: 241-247.
25. Franchi L, Munoz-Planillo R, Reimer T, Eigenbrod T, Nunez G: Inflammasomes as microbial sensors. Eur J Immunol 2010; 40: 611- 615.
26. Nett MA, Cerretti DP, Berson DR, Seavitt J, Gilbert DJ, Jenkins NA, Copeland NG, Black RA, Chaplin DD: Molecular cloning of the murine IL-1? converting enzyme cDNA. J Immunol 1992; 149: 3254-3259.
27. Kahlenberg JM, Lundberg KC, Kertesy SB, Qu Y, Dubyak GR: Potentiation of caspase-1 activation by the P 2 X 7 receptor is dependent on TLR signals and requires NF-?B-driven protein synthesis. J Immunol 2005; 175: 7611- 7622.
28. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes- Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E: Cutting edge: NF-?Bactivating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009; 183: 787-791.
29. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991-1045.
30. Kono H, Rock KL: How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8: 279-289.
31. Shi Y, Evans JE, Rock KL: Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-521.
32. Mendez R, Zheng Z, Fan Z, Rajagopalan S, Sun Q, Zhang K: Exposure to fine airborne particulate matter induces macrophage infiltration, unfolded protein response, and lipid deposition in white adipose tissue. Am J Transl Res 2013; 5: 224-234.
33. Tan HH, Fiel MI, Sun Q, Guo J, Gordon RE, Chen LC, Friedman SL, Odin JA, Allina J: Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol 2009; 6: 266-275.
34. Ix JH, Sharma K: Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol 2010; 21: 406-412.
35. Haukeland JW, Dahl TB, Yndestad A, Gladhaug IP, Loberg EM, Haaland T, Konopski Z, Wium C, Aasheim ET, Johansen OE, Aukrust P, Halvorsen B, Birkeland KI: Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol 2012; 166: 503- 510.
36. Miura K, Yang L, van Rooijen N, Brenner DA, Ohnishi H, Seki E: Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 2013; 57: 577-589.
37. Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA, Seki E: Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1? in mice. Gastroenterology 2010; 139: 323-334. e7.
38. De Roos B, Rungapamestry V, Ross K, Rucklidge G, Reid M, Duncan G, Horgan G, Toomey S, Browne J, Loscher CE, Mills KH, Roche HM: Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics 2009; 9: 3244-3256.
39. Mencin A, Kluwe J, Schwabe RF: Toll-like receptors as targets in chronic liver diseases. Gut 2009; 58: 704-720.
40. Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, Caviglia JM, Khiabanian H, Adeyemi A, Bataller R, Lefkowitch JH, Bower M, Friedman R, Sartor RB, Rabadan R, Schwabe RF: Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 2012; 21: 504- 516.
41. Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G: Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 2011; 54: 133-144.
42. Stienstra R, Saudale F, Duval C, Keshtkar S, Groener JE, van Rooijen N, Staels B, Kersten S, Muller M: Kupffer cells promote hepatic steatosis via interleukin-1?-dependent suppression of peroxisome proliferator-activated receptor-? activity. Hepatology 2010; 51: 511-522.
43. Kamari Y, Shaish A, Vax E, Shemesh S, Kandel- Kfir M, Arbel Y, Olteanu S, Barshack I, Dotan S, Voronov E, Dinarello CA, Apte RN, Harats D: Lack of interleukin-1? or interleukin-1? inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol 2011; 55: 1086-1094.
44. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA: Inflammasome- mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012; 482: 179-185.
45. Ouyang X, Ghani A, Malik A, Wilder T, Colegio OR, Flavell RA, Cronstein BN, Mehal WZ: Adenosine is required for sustained inflammasome activation via the A2a receptor and the HIF-1? pathway. Nat Commun 2013; 4: 2909.
46. Chhabra P, Linden J, Lobo P, Douglas Okusa M, Lewis Brayman K: The immunosuppressive role of adenosine A2a receptors in ischemia reperfusion injury and islet transplantation. Curr Diabetes Rev 2012; 8: 419-433.
47. Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, Rey S, Hammers H, Chang D, Pili R, Dang CV, Liu JO, Semenza GL: Digoxin and other cardiac glycosides inhibit HIF-1? synthesis and block tumor growth. Proc Natl Acad Sci USA 2008; 105: 19579-19586.
48. Ramachandran P, Iredale JP: Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol 2012; 56: 1417-1419.
49. Wynn TA, Barron L: Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010; 30: 245-257.
50. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP: Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005; 115: 56-65.
51. Mitchell C, Couton D, Couty JP, Anson M, Crain AM, Bizet V, Renia L, Pol S, Mallet V, Gilgenkrantz H: Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am J Pathol 2009; 174: 1766-1775.
52. Miura K, Yang L, van Rooijen N, Ohnishi H, Seki E: Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol 2012; 302:G1310-G1321.
53. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C, Tacke F: Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009; 50: 261-274.
54. Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali-Bostwick CA, Katsikis PD: The inflammasome activating caspase-1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum 2011; 63: 3563-3574.
55. Watanabe A, Sohail MA, Gomes DA, Hashmi A, Nagata J, Sutterwala FS, Mahmood S, Jhandier MN, Shi Y, Flavell RA, Mehal WZ: Inflammasome-mediated regulation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2009; 296:G1248-G1257.
56. Watanabe A, Hashmi A, Gomes DA, Town T, Badou A, Flavell RA, Mehal WZ: Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via Toll-like receptor-9. Hepatology 2007; 46: 1509-1518.
57. Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min SY, Kurt-Jones EA, Szabo G: IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 2012; 122: 3476-3489.